Atoltivimab
Product Specifications
CAS Number
2135632-29-8
Target
Virus Protease
Related Pathways
Microbiology/Virology
Bioactivity
Atoltivimab (REGN3470), also known as maftivimab/odesivimab (Inmazeb), represents the first monoclonal antibody approved by the Food and Drug Administration (FDA) to combat Zaire ebolavirus (EBOV) infection [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2052219-01 0.1 mL
FITC-Linked Polyclonal Antibody to Clusterin (CLU)
Sign In for Pricing
View Details MBS2052219-02 0.2 mL
FITC-Linked Polyclonal Antibody to Clusterin (CLU)
Sign In for Pricing
View Details 
MBS2052219-03 0.5 mL
FITC-Linked Polyclonal Antibody to Clusterin (CLU)
Sign In for Pricing
View Details MBS2052219-04 1 mL
FITC-Linked Polyclonal Antibody to Clusterin (CLU)
Sign In for Pricing
View Details